A recently established technique termed pharming uses genetically
modified plants and animals for the production of biopharmaceuticals.
The present interdisciplinary study comprises an extended overview of
the state of the art of pharming, as well as in depth analyses of the
environmental risks and other ethical and legal issues of pharming.
Public attitudes to pharming are investigated on the basis of an
original survey in 15 countries worldwide. The study concludes with
specific recommendations addressed towards science, industry and
politics.